US Patent Issued to APOGEE PHARMACEUTICALS on Sept. 9 for "Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,137, issued on Sept. 9, was assigned to APOGEE PHARMACEUTICALS INC. (Burnaby, Canada).

"Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof" was invented by Safwat Mohamed Rabea (Richmond, Canada), KK Durgarao Viswanadham (Vancouver, Canada), Gopi Kishore Valluru (Saint-Laurent, Canada) and Kaiji Hu (Burnaby, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to fatty acid amide hydrolase (FAAH) modulators, inhibitors, or FAAH modulators and inhibitors and methods and uses thereof. The FAAH modulators, inhibitors, or FAAH modulators and inhibitors may be compounds having Formula...